ROCHESTER, N.Y., April 29, 2025 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today that it priced the public offering of $500.0 million aggregate principal amount of 4.800% Senior Notes due 2030 (the "notes") for a public offering price of 99.824% of the principal amount of the notes. The notes will be senior obligations that rank equally with all of Constellation’s other senior unsecured indebtedness.
Closing of the offering is expected to occur on May 1, 2025, subject to the satisfaction of customary closing conditions. Constellation intends to use the net proceeds from the offering for general corporate purposes, including repayment of commercial paper and other indebtedness, working capital, funding capital expenditures, and other business opportunities.
BofA Securities, Inc., BNP Paribas Securities Corp., Goldman Sachs & Co. LLC, and J.P. Morgan Securities LLC are acting as the joint book-running managers of the offering. The notes are being offered only by means of a prospectus, including a prospectus supplement, copies of which may be obtained by contacting BofA Securities, Inc. toll-free at (800) 294-1322 or emailing dg.prospectus_requests@bofa.com, BNP Paribas Securities Corp. toll-free at (800) 854-5674, contacting Goldman Sachs & Co. LLC toll-free at (866) 471-2526 or emailing prospectus-ny@ny.email.gs.com, or contacting J.P. Morgan Securities LLC collect at (212) 834-4533. Alternatively, the prospectus and prospectus supplement may be obtained by visiting EDGAR on the SEC website at https://www.sec.gov.
This announcement does not constitute an offer to sell or a solicitation of an offer to buy notes. The notes will not be offered or sold in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful.
ABOUT CONSTELLATION BRANDS
Constellation Brands is an international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy. Constellation’s brand portfolio includes Modelo Especial, Corona Extra, Pacifico, Robert Mondavi Winery, Kim Crawford, The Prisoner Wine Company, High West Whiskey, Casa Noble Tequila, and Mi CAMPO Tequila.
FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Statements which are not historical facts and relate to future plans, events, or performance are forward-looking statements that are based upon management’s current expectations and are subject to risks and uncertainties. The forward-looking statements are based on management's current expectations and should not be construed in any manner as a guarantee that such events or results will in fact occur. All forward-looking statements speak only as of the date of this news release and Constellation Brands undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Detailed information regarding risk factors with respect to the company and the offering are included in the company’s filings with the SEC, including the prospectus and prospectus supplement for the offering.
MEDIA CONTACTS | INVESTOR RELATIONS CONTACTS | ||||
Amy Martin | 585-678-7141 | amy.martin@cbrands.com | Joseph Suarez | 773-551-4397 | joseph.suarez@cbrands.com |
Carissa Guzski | 315-525-7362 | carissa.guzski@cbrands.com | Snehal Shah | 847-385-4940 | snehal.shah@cbrands.com |
David Paccapaniccia | 585-282-7227 | david.paccapaniccia@cbrands.com |
A downloadable PDF copy of this news release can be found here
http://ml.globenewswire.com/Resource/Download/a719b7ce-2e86-455c-bfc2-90b330568c22
-
Constellation Brands Prices Offering of Senior NotesROCHESTER, N.Y., April 29, 2025 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today that2025-04-30
-
Sandoz enters global collaboration license agreement with HenliusSandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications MEDI2025-04-30
-
Yaqrit 将于 5 月 7 日至 10 日在欧洲肝脏研究协会 (EASL) 大会上展示其临床进展分享的数据为其在肝性脑病、急性慢性肝衰竭 (ACLF) 和失代偿性肝硬化领域的关键高级临床试验提供重要支持 管理层将出席此次会议 伦敦, April 29, 2025 (GLO2025-04-30
-
隧道工程网助力行业数字化转型升级!随着城市化进程不断加快和基础设施建设的深入推进,建筑工程行业迎来了高速发展的新阶段。作为其中的重要组成部分,隧道工程在交通、能源、市政等领域扮演着不可替代2025-04-30
-
科技赋能多元拓市,宝安制造硬核出海香港 2025年4月29日 /美通社/ -- 2025年4月,宝安区商务局组织300多家企业亮相2025四月环球资源香港展,以"科技赋能、多元拓市"为核心策略,在亚洲顶级电子盛会上集2025-04-29